At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Jul 30, 2026 at 17:58 ET
Three C-suite insiders at Nurix Therapeutics (CFO, CSO, CLO) exercised stock options and immediately sold a combined ~$246K in open-market sales on July 30, 2026. The sales are small relative to the $2.4B market cap (~0.01%) and coincide with option exercises, suggesting tax-covering or liquidity-driven sales rather than a bearish signal. The cluster is not informative per academic literature, insider sales are weak predictors, and the dollar amount is trivial.
- Three C-suite insiders (CFO, CSO, CLO) sold a combined ~$246K in open-market sales on July 30, 2026.
- All sales followed option exercises at $0 strike, indicating a cashless exercise-to-sell pattern for tax or liquidity purposes.
- Total sales represent ~0.01% of NRIX's $2.4B market cap, well below the 0.1% materiality threshold.
- The cluster is a single-day event with all trades at the same price ($23.38), consistent with a coordinated vesting/blackout-window opening.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access